Characterization of a vertebrate neuromuscular junction that demonstrates selective resistance to Botulinum toxin

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 3, 1999, Pages 1509-1516

  Coffield, Julie A ^a   Bakry, Nabil M ^b   Maksymowych, Andrew B ^b   Simpson, Lance L ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LATROTOXIN; BETA BUNGAROTOXIN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CELL SURFACE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; ELECTROPHYSIOLOGY; EXOCYTOSIS; FROG; HUMAN; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR SYNAPSE; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR SENSITIVITY;

ANIMALS; BOTULINUM TOXIN TYPE A; BOTULINUM TOXINS; BRAIN; EVOKED POTENTIALS; EXOCYTOSIS; KINETICS; MICE; MOTOR ENDPLATE; MUSCLE, SKELETAL; NERVE ENDINGS; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; RANA PIPIENS; SENSITIVITY AND SPECIFICITY; SYNAPTIC TRANSMISSION; SYNAPTOSOMES;

EID: 0032995728     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Abe T, Alem S and Miledi R (1977) Isolation and characterization of presynaptically acting neurotoxins from the venom of Bungarus snakes. Eur J Biochem 80:1-12.
2. Ahnert-Hilger G and Bigalke H (1995) Molecular aspects of tetanus and botulinum neurotoxin poisoning Prog Neurobiol 46:83-96.
3. Bakry N, Kamata Y and Simpson LL (1991a) Lectins from Triticum vulgaris and Limax flavus are universal antagonists of botulinum neurotoxin and tetanus toxin. J Pharmacol Exp Ther 258:830-836.
4. Bakry N, Kamata Y, Sorensen R and Simpson LL (1991b) Tetanus toxin and neuronal membranes: The relationship between binding and toxicity. J Pharmacol Exp Ther 258:613-619.
5. Bakry NM, Kamata Y and Simpson LL (1997) Expression of botulinum toxin binding sites in Xenopus oocytes. Infect Immun 65:2225-2232.
6. Betz WJ and Bewick GS (1992) Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction Science (Wash DC) 255:200-203.
7. Betz WJ and Bewick GS (1993) Optical and electrophysiological monitoring of transmitter release and synaptic vesicle recycling at the frog neuromuscular junction. J Physiol (Lond) 460:287-309.
8. Betz WJ, Mao F and Bewick GS (1992) Activity-dependent fluorescent staining and destaining of living vertebrate motor nerve terminals. J Neurosci 12:363-375.
9. Burgen ASV, Dickens F and Zatman LJ (1949) The action of botulinum toxin on the neuromuscular junction. J Physiol (Lond) 109:10-24.
10. Caratsch CG, Miledi R and Strong PN (1985) Influence of divalent cations on the phospholipase-independent action of á-bungarotoxin at frog neuromuscular junctions. J Physiol (Lond) 363:169-179.
11. Coffield JA, Bakry N, Zhang R-D, Carlson J, Gomella LG and Simpson LL (1997) In vitro characterization of botulinum toxin types A, C and D action on human tissues: Combined electrophysiologic, pharmacologic and molecular biologic approaches. J Pharmacol Exp Ther 280:1489-1498.
12. Henkel AW and Betz WJ (1995) Monitoring of Black Widow spider venom (BWSV) induced exo- and endocytosis in living frog motor nerve terminals with FM1-43 Neuropharmacology 34:1397-1406.
13. Henkel AW, Simpson LL, Ridge RMAP and Betz WJ (1996) Synaptic vesicle movements monitored by fluorescence recovery after photobleaching in nerve terminals stained with FM1-43 J Neurosci 16:3960-3967.
14. Kamata Y, Kimura Y, Hiroi T, Sakaguchi G and Kozaki S (1993) Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin. Biochim Biophys Acta 1156:213-218.
15. Kitamura M, Iwamori M and Nagal Y (1980) Interaction between Clostridium botulinum neurotoxin and gangliosides. Biochim Biophys Acta 628:328-335.
16. Kraszewski K, Mundigl O, Daniell L, Verderio C, Matteoli M and De Camilli P (1995) Synaptic vesicle dynamics in living cultured hippocampal neurons vizualized with CY-3 conjugated antibodies directed against the lumenal domain of synaptotagmin. J Neurosci 15:4328-4342.
17. McPherson GA (1982) EBDA, User Manual Computer Program.
18. Miledi R and Spitzer NC (1974) Absence of action potentials in frog slow muscle fibres paralysed by botulinum toxin. J Physiol (Lond) 241:183-199.
19. Montecucco C (1986) How do tetanus and botulinum toxins bind to neuronal membranes? Trends Biochem Sci 11:314-317.
20. Montecucco C and Schiavo G (1994) Mechanism of action of tetanus and botulinum neurotoxins. Mol Microbiol 13:1-8.
21. Mundigl O, Verderio C, Kraszewski K, DeCamilli P and Matteoli M (1995) A radioimmunoassay to monitor synaptic activity in hippocampal neurons in vitro. Eur J Cell Biol 66:246-256. mc>Nishiki T, Kamata Y, Nemoto Y, Omori A, Ito T, Takahashi M and Kozaki S (1994) Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem 269: 10498-10503.
22. Mundigl O, Verderio C, Kraszewski K, DeCamilli P and Matteoli M (1995) A radioimmunoassay to monitor synaptic activity in hippocampal neurons in vitro. Eur J Cell Biol 66:246-256. mc>Nishiki T, Kamata Y, Nemoto Y, Omori A, Ito T, Takahashi M and Kozaki S (1994) Identification of protein receptor for Clostridium botulinum type B neurotoxin in rat brain synaptosomes. J Biol Chem 269: 10498-10503.
23. Nishiki T, Ogasawara J, Kamata Y and Kozaki S (1993) Solubilization and characterization of the acceptor for Clostridium botulinum type B neurotoxin from rat brain synaptic membranes. Biochim Biophys Acta 1158:333-338.
24. Nishiki T, Tokuyama Y, Kamata Y, Nemoto Y, Yoshida A, Sato K, Sekiguchi M, Takahashi M and Kozaki S (1996) The high affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/ GD1a. FEBS Lett 378:253-257.
25. Patarnello T, Bargelloni L, Rossetto O, Schiavo G and Montecusso C (1993) Neurotransmission and secretion. Nature (Lond) 364:581-532.
26. Poulain B, Wadsworth JDF, Shone CC, Mochida S, Lande S, Melling J, Dolly JO and Taue L (1989) Multiple domains of botulinum neurotoxin contribute to its inhibition of transmitter release in Aplysia neurons. J Biol Chem 264:21928-21933.
27. Pumplin DW and Reese TS (1977) Action of brown widow spider venom and botulinum toxin on the frog neuromuscular junction examined with the freeze-fracture technique. J Physiol (Lond) 273:443-457.
28. Schagger H and Von Jagow G (1987) Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 166:368-379.
29. Schiavo G, Rossetto O, Benfenati F, Poulain B and Montecucco C (1994) Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroeocytosis apparatus. Ann NY Acad Sci 710:65-75.
30. Schiavo G, Rossetto O, Tonello F and Montecucco C (1995) Intracellular targets and metalloprotease activity of tetanus and botulism neurotoxins. Rev Curr Topics Microbiol Immunol 195:257-274.
31. Simpson LL (1981) The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 33:155-188.
32. Simpson LL and Rapport MM (1971) Ganglioside inactivation of botulinum toxin. J Neurochem 18:1341-1343.
33. Simpson LL (1980) Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther 212:16-21.
34. Simpson LL (1982) The interaction between aminoquinolines and presynaptically acting neurotoxins. J Pharmacol Exp Ther 222:43-48.
35. Simpson LL (1983) Ammonium chloride and methylamine hydrochloride antagonize clostridial neurotoxins. J Pharmacol Exp Ther 225:546-552.
36. Simpson LL (1989) Botulinum Neurotoxin and Tetanus Toxin, pp 1-422, Academic Press, San Diego.
37. Simpson LL, Coffield JA and Bakry N (1994) Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins. J Pharmacol Exp Ther 269:256-262.
38. Simpson LL and DasGupta BR (1983) Botulinum neurotoxin type E: Studies on mechanism of action and on structure-activity relationships. J Pharmacol Exp Ther 224:135-140.
39. Simpson LL, Schmidt JJ and Middlebrook JL (1988) Isolation and characterization of the botulinum neurotoxins. Methods Enzymol 165:76-85.